SIS.L
Science in Sport plc [SIS.L] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
SIS.L Stock Summary
Top 10 Correlated Stocks
SIS.L
In the News
SIS.L Financial details
Company Rating
Sell
Market Cap
28.39M
Income
-14.18M
Revenue
98.21M
Book val./share
0.22
Cash/share
0.01
Dividend
-
Dividend %
-
Employees
320
Optionable
No
Shortable
Yes
Earnings
27 Jun 2024
P/E
-1.9
Forward P/E
-
PEG
-0.21
P/S
0.42
P/B
0.52
P/C
1555
P/FCF
-1.62
Quick Ratio
0.04
Current Ratio
1.08
Debt / Equity
0.39
LT Debt / Equity
0.36
-
-
EPS (TTM)
-0.1
EPS next Y
-
EPS next Q
-
EPS this Y
53.82%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-0.92%
Revenue last 5Y
24.5%
Revenue Q/Q
9.34%
EPS Q/Q
-26.46%
-
-
-
-
SMA20
6.67%
SMA50
6.67%
SMA100
33.33%
Inst Own
-
Inst Trans
-
ROA
-14%
ROE
-26%
ROC
-0.18%
Gross Margin
42%
Oper. Margin
-15%
Profit Margin
-17%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
8.3-18.0
52W High
-13.61%
52W Low
+94.38%
RSI
39
Rel Volume
-
Avg Volume
213.69K
Volume
14
Perf Week
-1.27%
Perf Month
-7.16%
Perf Quarter
26.94%
Perf Half Y
29.58%
-
-
-
-
Beta
0.5
-
-
Volatility
0.07%, 0.2%
Prev Close
-1.27%
Price
15.55
Change
0%
SIS.L Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
| Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.3 | 0.41 | 0.39 | 0.47 | 0.46 | |
| Net income per share | -0.08 | -0.05 | -0.01 | -0.05 | -0.08 | |
| Operating cash flow per share | -0.09 | 0 | 0.02 | 0 | -0.06 | |
| Free cash flow per share | -0.11 | -0.02 | 0.01 | -0.05 | -0.12 | |
| Cash per share | 0.11 | 0.04 | 0.08 | 0.04 | 0.01 | |
| Book value per share | 0.7 | 0.37 | 0.37 | 0.33 | 0.29 | |
| Tangible book value per share | -0.02 | -0.04 | 0.12 | 0.09 | 0.07 | |
| Share holders equity per share | 0.7 | 0.37 | 0.37 | 0.33 | 0.29 | |
| Interest debt per share | 0.02 | 0.01 | 0.01 | 0.09 | 0.16 | |
| Market cap | 38.57M | 54M | 45.93M | 91.46M | 19.44M | |
| Enterprise value | 30.57M | 49.7M | 36.32M | 99.02M | 40.29M | |
| P/E ratio | -6.56 | -9.61 | -26.58 | -13.42 | -1.78 | |
| Price to sales ratio | 1.81 | 1.07 | 0.91 | 1.46 | 0.3 | |
| POCF ratio | -6.01 | -674.94 | 14.61 | -564.56 | -2.25 | |
| PFCF ratio | -4.89 | -22.01 | 44.59 | -13.65 | -1.17 | |
| P/B Ratio | 0.77 | 1.19 | 0.96 | 2.08 | 0.48 | |
| PTB ratio | 0.77 | 1.19 | 0.96 | 2.08 | 0.48 | |
| EV to sales | 1.43 | 0.98 | 0.72 | 1.58 | 0.63 | |
| Enterprise value over EBITDA | -7.9 | -30.49 | 37.29 | -62.51 | -8.04 | |
| EV to operating cash flow | -4.76 | -621.3 | 11.55 | -611.22 | -4.66 | |
| EV to free cash flow | -3.88 | -20.26 | 35.26 | -14.78 | -2.43 | |
| Earnings yield | -0.15 | -0.1 | -0.04 | -0.07 | -0.56 | |
| Free cash flow yield | -0.2 | -0.05 | 0.02 | -0.07 | -0.85 | |
| Debt to equity | 0 | 0.02 | 0.02 | 0.28 | 0.54 | |
| Debt to assets | 0 | 0.02 | 0.01 | 0.17 | 0.29 | |
| Net debt to EBITDA | 2.07 | 2.63 | -9.86 | -4.77 | -4.16 | |
| Current ratio | 3.02 | 2.16 | 2.26 | 1.68 | 1.08 | |
| Interest coverage | -4.52 | -191.65 | -27.77 | -43.89 | -12.97 | |
| Income quality | 1.09 | 0.01 | -1.82 | 0.02 | 0.79 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.18 | 0.1 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0.01 | 0.01 | 0 | |
| Intangibles to total assets | 0.56 | 0.56 | 0.51 | 0.43 | 0.41 | |
| Capex to operating cash flow | 0.23 | 29.66 | -0.67 | 40.36 | 0.92 | |
| Capex to revenue | -0.07 | -0.05 | -0.04 | -0.1 | -0.12 | |
| Capex to depreciation | -1.58 | -0.86 | -0.67 | -1.8 | -1.65 | |
| Stock based compensation to revenue | 0.09 | 0.02 | 0 | 0.05 | 0 | |
| Graham number | 1.14 | 0.62 | 0.33 | 0.62 | 0.72 | |
| ROIC | -0.11 | -0.1 | -0.03 | -0.1 | -0.14 | |
| Return on tangible assets | -0.22 | -0.22 | -0.06 | -0.16 | -0.24 | |
| Graham Net | 0.02 | 0.02 | 0.05 | -0.08 | -0.14 | |
| Working capital | 16.07M | 12.06M | 15.22M | 10.56M | 1.86M | |
| Tangible asset value | 16.08M | 12.13M | 15.95M | 12.36M | 9.55M | |
| Net current asset value | 13.61M | 8.75M | 12.38M | -3.88M | -11.32M | |
| Invested capital | 0 | 0.02 | 0.02 | 0.28 | 0.54 | |
| Average receivables | 0 | 5.46M | 10.38M | 11.26M | 14.6M | |
| Average payables | 2.94M | 5.17M | 5.56M | 6.54M | 6.31M | |
| Average inventory | 4.91M | 6.62M | 6.56M | 7.71M | 7.54M | |
| Days sales outstanding | 0 | 78.86 | 71.34 | 74 | 94.57 | |
| Days payables outstanding | 181.7 | 73.09 | 77.02 | 89.44 | 49.35 | |
| Days of inventory on hand | 276.86 | 79.02 | 98.84 | 98.85 | 65.77 | |
| Receivables turnover | 0 | 4.63 | 5.12 | 4.93 | 3.86 | |
| Payables turnover | 2.01 | 4.99 | 4.74 | 4.08 | 7.4 | |
| Inventory turnover | 1.32 | 4.62 | 3.69 | 3.69 | 5.55 | |
| ROE | -0.12 | -0.12 | -0.04 | -0.15 | -0.27 | |
| Capex per share | -0.02 | -0.02 | -0.02 | -0.05 | -0.06 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
| Metric | History | 2021-06-30 | 2021-12-31 | 2022-06-30 | 2022-12-31 | 2023-06-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0 | 0 | 0.24 | 0.21 | 0.2 | |
| Net income per share | 0 | 0 | -0.05 | -0.03 | -0.02 | |
| Operating cash flow per share | 0 | 0 | -0.03 | -0.03 | 0 | |
| Free cash flow per share | 0 | 0 | -0.07 | -0.05 | -0.01 | |
| Cash per share | 0 | 0 | -0.02 | 0.01 | 0.01 | |
| Book value per share | 0 | 0 | 0.28 | 0.27 | 0.22 | |
| Tangible book value per share | 0 | 0 | 0.05 | 0.06 | 0.04 | |
| Share holders equity per share | 0 | 0 | 0.28 | 0.27 | 0.22 | |
| Interest debt per share | 0 | 0 | 0.11 | 0.15 | 0.09 | |
| Market cap | 0 | 0 | 60.51M | 20.7M | 22.41M | |
| Enterprise value | -7.47M | 7.56M | 77.98M | 41.55M | 35.83M | |
| P/E ratio | 0 | 0 | -2.13 | -1.36 | -1.72 | |
| Price to sales ratio | 0 | 0 | 1.87 | 0.66 | 0.65 | |
| POCF ratio | 0 | 0 | -13.01 | -4.8 | 50.14 | |
| PFCF ratio | 0 | 0 | -6.55 | -2.7 | -24.77 | |
| P/B Ratio | 0 | 0 | 1.61 | 0.51 | 0.6 | |
| PTB ratio | 0 | 0 | 1.61 | 0.51 | 0.6 | |
| EV to sales | 0 | 0 | 2.42 | 1.32 | 1.04 | |
| Enterprise value over EBITDA | 0 | 0 | -23.35 | 106.81 | 37.68 | |
| EV to operating cash flow | 0 | 0 | -16.77 | -9.63 | 80.16 | |
| EV to free cash flow | 0 | 0 | -8.44 | -5.41 | -39.59 | |
| Earnings yield | 0 | 0 | -0.12 | -0.18 | -0.15 | |
| Free cash flow yield | 0 | 0 | -0.15 | -0.37 | -0.04 | |
| Debt to equity | 0.01 | 0.28 | 0.39 | 0.54 | 0.39 | |
| Debt to assets | 0.01 | 0.17 | 0.21 | 0.29 | 0.18 | |
| Net debt to EBITDA | 0 | 0 | -5.23 | 53.59 | 14.11 | |
| Current ratio | 1.8 | 1.68 | 1.16 | 1.08 | 1.01 | |
| Interest coverage | 0 | 0 | -17.44 | -4.42 | -2.4 | |
| Income quality | 0 | 0 | 0.65 | 1.13 | -0.14 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.48 | 0.43 | 0.44 | 0.41 | 0.37 | |
| Capex to operating cash flow | 0 | 0 | 0.99 | 0.78 | -3.02 | |
| Capex to revenue | 0 | 0 | -0.14 | -0.11 | -0.04 | |
| Capex to depreciation | 0 | 0 | -1.79 | -1.5 | -0.49 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 0 | 0 | 0.58 | 0.4 | 0.3 | |
| ROIC | 0 | 0 | -0.09 | -0.03 | -0.03 | |
| Return on tangible assets | 0 | 0 | -0.18 | -0.08 | -0.06 | |
| Graham Net | 0 | 0 | -0.15 | -0.13 | -0.13 | |
| Working capital | 12.86M | 10.56M | 2.82M | 1.86M | 217K | |
| Tangible asset value | 15.96M | 12.36M | 6.63M | 9.55M | 7.5M | |
| Net current asset value | 9.67M | -3.88M | -12.56M | -11.32M | -13.09M | |
| Invested capital | 0.01 | 0.28 | 0.39 | 0.54 | 0.39 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 0 | 0 | 0 | 0 | 0 | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 0 | 0 | 41 | 47.22 | 51.56 | |
| Days payables outstanding | 0 | 0 | 69.14 | 21.76 | 110.86 | |
| Days of inventory on hand | 0 | 0 | 37.32 | 29 | 37.82 | |
| Receivables turnover | 0 | 0 | 2.19 | 1.91 | 1.75 | |
| Payables turnover | 0 | 0 | 1.3 | 4.14 | 0.81 | |
| Inventory turnover | 0 | 0 | 2.41 | 3.1 | 2.38 | |
| ROE | 0 | 0 | -0.19 | -0.09 | -0.09 | |
| Capex per share | 0 | 0 | -0.03 | -0.02 | -0.01 |
SIS.L Frequently Asked Questions
What is Science in Sport plc stock symbol ?
Science in Sport plc is a GB stock and trading under the symbol SIS.L
What is Science in Sport plc stock quote today ?
Science in Sport plc stock price is $15.55 today.
Is Science in Sport plc stock public?
Yes, Science in Sport plc is a publicly traded company.
Company Profile
- Volume Average 213.69K
- Market Capitalization 28.39M
- Employee 320
- CEO Mr. Daniel Malachy Lampard
- Headquarters London,GB
- IPO Date 2013-08-09
-
Website
https://www.scienceinsport.com 
Science in Sport plc, together with its subsidiaries, develops, manufactures, and markets sports nutrition products for professional athletes, sports and fitness enthusiasts, and the active lifestyle community. The company offers energy bars, gels, powders, and shots; hydration products, such as gels, tablets, and powders; recovery products; supplements; and vitamins. It sells its products under the PhD Nutrition and Science in Sport brand names through retail distribution, including supermarkets and high street chains; specialist sports retailers; grocers; convenience and discount retailers; and international wholesalers, retailers, and distributors, as well as phd.com and scienceinsport.com digital platforms, third-party online sites in the United Kingdom, rest of Europe, the United States, and internationally. Science in Sport plc was founded in 1992 and is headquartered in London, the United Kingdom.
